Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies
MetadataShow full item record
Wischik , C M , Wischik , D J , Storey , J M D & Harrington , C R 2010 , Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies . in A Martinez (ed.) , Emerging drugs and targets for Alzheimer's disease : Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism . vol. 1 , RSC Drug Discovery Series , Cambridge , pp. 210-232 . https://doi.org/10.1039/9781849731065
Uncorrected proof - Publishers have granted rights to make available on internet.